Pulmonary vasodilators in patients with advanced chronic kidney disease and pre‐capillary pulmonary hypertension—A case series
RAUL LEGUIZAMON, Christian Witzke(Einstein Medical Center Philadelphia), Ian D. McLaren, Alexander Prendergast(Jefferson Einstein Philadelphia Hospital), Jose Manuel Martinez Manzano(Brigham and Women's Hospital), Phuuwadith Wattanachayakul(Einstein Healthcare Network), Tara John, Simone A. Jarret, Andrew Geller, John Malin, Rasha Khan(Einstein Medical Center Philadelphia), Kevin Bryan Lo(Einstein Medical Center Philadelphia)
Cited by 1
Related Papers
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
|Circulation|2023|1.7k
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association
|Circulation|2023|1.1k
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|105
Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States
|The American Journal of Cardiology|2022|78
Single Cell RNA-seq and Mass Cytometry Reveals a Novel and a Targetable Population of Macrophages in Idiopathic Pulmonary Fibrosis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|48